Source: Amplexor NV Blog

Amplexor NV Blog Looking back on another high-profile year in pharma media

2020 has certainly been a year like no other, with the world brought to its knees by a raging pandemic as the search for a vaccine continues apace. The year also saw a wide range of Amplexor thought leadership in pharma titles around the world. Here we look back at some of the topics we covered and link to some of the best articles.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Mark Evenepoel's photo - President & CEO of Amplexor NV

President & CEO

Mark Evenepoel

CEO Approval Rating

90/100

Read more